Non alcoholic fatty liver disease in southern Iran: a population based study.
about
Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in IranThe Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.Prevalence and sonographic changes compatible with fatty liver disease in patients referred for abdominal ultrasound examination in Aracaju, SE.Data from a randomized and controlled trial of LCarnitine prescription for the treatment for Non- Alcoholic Fatty Liver Disease.Prevalence of Nonalcoholic Fatty Liver Disease and its Related Metabolic Risk Factors in Isfahan, IranThe effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.Major Components of Metabolic Parameters and Nutritional Intakes in Different Genotypes of Adiponectin +276 G>T Gene Polymorphism in Non-Diabetes and Non-Alcoholic Iranian Fatty Liver Patients.Alcoholic liver disease: treatmentNAFLD Prevalence in a Young Cadaveric Organ Donor Population.Association between non-alcoholic fatty liver disease and ischemic strokePrevalence of obesity and overweight in adults and children in Iran; a systematic review.Effect of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver DiseasePrevalence of hepatic steatosis and associated factors in Iranian patients with chronic hepatitis C.Major components of metabolic syndrome and nutritional intakes in different genotype of UCP2 -866G/A gene polymorphisms in patients with NAFLD.How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease?Prediction and Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) and Identification of Its Associated Factors Using the Classification Tree Method.The Reliability of Classification of Terminal Nodes in GUIDE Decision Tree to Predict the Nonalcoholic Fatty Liver Disease.Prevalence of non-alcoholic fatty liver disease in patients with coronary artery disease.Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol.Astragaloside IV Inhibits Triglyceride Accumulation in Insulin-Resistant HepG2 Cells via AMPK-Induced SREBP-1c Phosphorylation.Waist circumference is a mediator of dietary pattern in Non-alcoholic fatty liver disease.Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trialThe role of anthropometric indices in the prediction of non-alcoholic fatty liver disease in the PERSIAN Guilan Cohort study (PGCS)
P2860
Q28079534-3866522B-E067-4674-A201-A517EDED078FQ30382395-342B2426-440F-424C-9E20-7C03E201B06FQ30390099-98582968-495D-46EB-912F-0ABE1F4FC43CQ30865139-8EBAA62B-9A56-48AD-A944-D7A0B665DB86Q33630744-290E82A3-C019-4B0F-A3EC-69FBE81F471CQ33776388-12E041A8-301A-4543-B9EA-3B38B0EF9E0AQ33883038-D51075FD-BAAD-42EA-BCF0-2F4679EDE8E2Q34255479-2997D931-1344-437F-89F6-DCDAA1D21EABQ34546142-74D80AC7-7365-4643-BB8B-EBA8AAA8F63DQ34558966-FB7A3483-B2EB-41E7-B08B-4D6CBBDB6D24Q34992407-103402C7-B6EA-40D6-A7AA-B7DDC8958A7AQ36279434-DF98AEC0-E02D-4F10-8DB4-519A16362E99Q36983260-0E333F6D-D6BA-47AD-8F2B-816D9BF0AC74Q37006682-B53782EB-214E-4A7B-A2F6-3FD0FB230199Q37401637-93ABEC62-F9DF-4EDC-AA61-3DAE25D81FF1Q37625823-D83F71FD-BE83-45CC-8445-47CD5A76E488Q39039524-F8255EB1-693D-4248-8C3E-63C0E5BA2259Q42328013-A4AB966F-179D-47C1-8F86-CB120702B02AQ47191893-78984C0A-7583-4A9F-A513-6CAA97936295Q53689698-816AC85C-4533-4F9D-A03C-87BD9DA7B32BQ55228911-DEF0A4F3-AAE4-470B-A317-661E4FECE79EQ57193549-36BCFCAD-8AE5-4AE2-8402-75BA8CCD6A38Q58570672-A99807A2-D6C0-43EB-99B2-DABFFF184592
P2860
Non alcoholic fatty liver disease in southern Iran: a population based study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Non alcoholic fatty liver disease in southern Iran: a population based study.
@en
Non alcoholic fatty liver disease in southern Iran: a population based study.
@nl
type
label
Non alcoholic fatty liver disease in southern Iran: a population based study.
@en
Non alcoholic fatty liver disease in southern Iran: a population based study.
@nl
prefLabel
Non alcoholic fatty liver disease in southern Iran: a population based study.
@en
Non alcoholic fatty liver disease in southern Iran: a population based study.
@nl
P2093
P2860
P50
P356
P1433
P1476
Non alcoholic fatty liver disease in southern Iran: a population based study
@en
P2093
Kamran Bagheri Lankarani
Meisam Babaeinejad
Mojtaba Mahmoodi
Nima Zamiri
Soheila Mehravar
P2860
P356
10.5812/HEPATMON.9248
P407
P50
P577
2013-05-23T00:00:00Z